• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5,6-二氯-1-β-D-呋喃核糖基苯并咪唑抑制HeLa细胞中核不均一RNA链的起始。

5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.

作者信息

Sehgal P B, Derman E, Molloy G R, Tamm I, Darnell J E

出版信息

Science. 1976 Oct 22;194(4263):431-3. doi: 10.1126/science.982026.

DOI:10.1126/science.982026
PMID:982026
Abstract

The nucleoside analog 5, 6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) at 75 to 150 micromolar concentrations inhibits the synthesis of nuclear heterogeneous RNA (hnRNA) in HeLa cells by 60 to 70 percent. The sedimentation profile of hnRNA labeled with (3H)uridine for 45 seconds after brief treatment (45, 90, or 180 seconds) with DRB showed a progressive decrease in the labeling of shorter hnRNA molecules relative to longer molecules. Prior exposure of the cells to actinomycin D, an inhibitor of RNA chain elongation, did not alter the sedimentation profile of hnRNA. These results suggest that DRB preferentially inhibits the initiation of hnRNA chains so that after exposure to DRB for a brief period the longer nascent chains still remain to be finished and thus incorporate a greater share of the pulse label. By progressively increasing the time of exposure to DRB, and measuring the rate of increase in the average size of the labeled, nascent RNA, it was estimated that the chains were growing at rates between 50 and 100 nucleotides per second.

摘要

核苷类似物5,6 - 二氯 - 1 -β - D - 呋喃核糖基苯并咪唑(DRB)在75至150微摩尔浓度下可抑制HeLa细胞中核不均一RNA(hnRNA)的合成达60%至70%。在用DRB进行短暂处理(45、90或180秒)后,用(3H)尿苷标记45秒的hnRNA沉降图谱显示,相对于较长分子,较短hnRNA分子的标记逐渐减少。细胞预先暴露于RNA链延伸抑制剂放线菌素D,并未改变hnRNA的沉降图谱。这些结果表明,DRB优先抑制hnRNA链的起始,因此在短暂暴露于DRB后,较长的新生链仍有待完成,从而掺入了更大比例的脉冲标记。通过逐步增加暴露于DRB的时间,并测量标记的新生RNA平均大小的增加速率,估计链的生长速率为每秒50至100个核苷酸。

相似文献

1
5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.5,6-二氯-1-β-D-呋喃核糖基苯并咪唑抑制HeLa细胞中核不均一RNA链的起始。
Science. 1976 Oct 22;194(4263):431-3. doi: 10.1126/science.982026.
2
The inhibition by DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells.DRB(5,6-二氯-1-β-D-呋喃核糖基苯并咪唑)对HeLa细胞中核不均一RNA和信使RNA产生的抑制作用。
Cell. 1976 Nov;9(3):473-80. doi: 10.1016/0092-8674(76)90092-1.
3
Short capped hnRNA precursor chains in HeLa cells: continued synthesis in the presence of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.HeLa细胞中短帽hnRNA前体链:在5,6-二氯-1-β-D-呋喃核糖基苯并咪唑存在下的持续合成
Biochemistry. 1980 Jun 10;19(12):2743-8. doi: 10.1021/bi00553a032.
4
Pulse and steady-state labelled and actinomycin D chased 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)-resistant hnRNA from uninfected HeLa cells.脉冲和稳态标记以及放线菌素D追踪未感染的HeLa细胞中对5,6-二氯-1-β-D-呋喃核糖基苯并咪唑(DRB)具有抗性的核不均一RNA(hnRNA)。
Acta Biochim Pol. 1983;30(3-4):311-24.
5
Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole.哺乳动物细胞中异质核RNA转录本的提前终止:5,6-二氯-1-β-D-呋喃核糖基苯并咪唑的增强作用。
Proc Natl Acad Sci U S A. 1979 Nov;76(11):5750-4. doi: 10.1073/pnas.76.11.5750.
6
Action of dichlorobenzimidazole riboside on RNA synthesis in L-929 and HeLa cells.二氯苯并咪唑核糖苷对L-929和HeLa细胞中RNA合成的作用。
J Cell Biol. 1976 May;69(2):229-40. doi: 10.1083/jcb.69.2.229.
7
Specific inhibition of hnRNA synthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Requirement of a free 3'-hydroxyl group, but not 2'- or 5'-hydroxyls.5,6-二氯-1-β-D-呋喃核糖基苯并咪唑对不均一核RNA合成的特异性抑制作用。需要游离的3'-羟基,但不需要2'-或5'-羟基。
Biochim Biophys Acta. 1982 May 31;697(2):213-20. doi: 10.1016/0167-4781(82)90079-3.
8
HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).海拉细胞的RNA和蛋白质合成。5,6-二氯-1-β-D-呋喃核糖基苯并咪唑(DRB)长期处理的影响。
Biochem Pharmacol. 1984 Feb 15;33(4):551-7. doi: 10.1016/0006-2952(84)90306-x.
9
Inhibition of Balbiani ring RNA synthesis at the initiation level.在起始水平抑制巴尔比亚尼环RNA合成。
Proc Natl Acad Sci U S A. 1975 Mar;72(3):947-50. doi: 10.1073/pnas.72.3.947.
10
5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro.5,6-二氯-1-β-D-呋喃核糖基苯并咪唑在体外抑制RNA聚合酶II的转录延伸。
J Biol Chem. 1989 Feb 5;264(4):2250-7.

引用本文的文献

1
RNA polymerase II speed: a key player in controlling and adapting transcriptome composition.RNA 聚合酶 II 速度:控制和适应转录组组成的关键因素。
EMBO J. 2021 Aug 2;40(15):e105740. doi: 10.15252/embj.2020105740. Epub 2021 Jul 13.
2
An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program.维甲酸诱导 HL-60 分化程序的有效模型。
Sci Rep. 2017 Oct 30;7(1):14327. doi: 10.1038/s41598-017-14523-5.
3
[Effects of 2-mercapto-1(β-4-pyridethyl) benzimidazole on the development and metabolism of the egg ofParacentrotus lividus].
[2-巯基-1(β-4-吡啶乙基)苯并咪唑对紫球海胆卵发育和代谢的影响]
Wilehm Roux Arch Dev Biol. 1977 Dec;182(4):293-304. doi: 10.1007/BF00848381.
4
RNA polymerase II transcription elongation control.RNA聚合酶II转录延伸控制
Chem Rev. 2013 Nov 13;113(11):8583-603. doi: 10.1021/cr400105n. Epub 2013 Aug 6.
5
Reflections on the history of pre-mRNA processing and highlights of current knowledge: a unified picture.对前体 mRNA 处理历史的反思及当前知识要点:一幅统一的画面。
RNA. 2013 Apr;19(4):443-60. doi: 10.1261/rna.038596.113. Epub 2013 Feb 25.
6
Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway.mRNA 输出的调控由 PI3 激酶/AKT 信号转导通路。
Mol Biol Cell. 2013 Apr;24(8):1208-21. doi: 10.1091/mbc.E12-06-0450. Epub 2013 Feb 20.
7
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity.4-(噻唑-5-基)-2-(苯氨基)嘧啶-5-甲腈 CDK9 抑制剂的构效关系和功能比较研究为同工酶选择性提供了依据。
J Med Chem. 2013 Feb 14;56(3):660-70. doi: 10.1021/jm301495v. Epub 2013 Jan 29.
8
Identification and validation of protein targets of bioactive small molecules.生物活性小分子的蛋白质靶标的鉴定和验证。
Bioorg Med Chem. 2012 Mar 15;20(6):1902-9. doi: 10.1016/j.bmc.2011.11.070. Epub 2011 Dec 20.
9
Fast transcription rates of RNA polymerase II in human cells.人类细胞中 RNA 聚合酶 II 的快速转录速率。
EMBO Rep. 2011 Dec 1;12(12):1280-5. doi: 10.1038/embor.2011.196.
10
Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?抑制真核生物转录:该选择哪种化合物?如何评估其活性?
Transcription. 2011 May;2(3):103-108. doi: 10.4161/trns.2.3.16172.